Search
Search Results
-
Mortality, incidence, and microbiological documentation of ventilated acquired pneumonia (VAP) in critically ill patients with COVID-19 or influenza
BackgroundData on ventilator associated pneumonia (VAP) in COVID-19 and influenza patients admitted to intensive care units (ICU) are scarce. This...
-
Effect of ICU quality control indicators on VAP incidence rate and mortality: a retrospective study of 1267 hospitals in China
PurposeTo investigate the effects of ICU quality control indicators on the VAP incidence rate and mortality in China throughout 2019.
...
-
Metagenomics for the microbiological diagnosis of hospital-acquired pneumonia and ventilator-associated pneumonia (HAP/VAP) in intensive care unit (ICU): a proof-of-concept study
BackgroundHospital-acquired and ventilator-associated-pneumonia (HAP/VAP) are one of the most prevalent health-care associated infections in the...
-
Diagnosing ventilator-associated pneumonia (VAP) in UK NHS ICUs: the perceived value and role of a novel optical technology
BackgroundDiagnosing ventilator-associated pneumonia (VAP) in an intensive care unit (ICU) is a complex process. Our aim was to collect, evaluate and...
-
Assessment of knowledge and compliance to evidence-based guidelines for VAP prevention among ICU nurses in Tanzania
BackgroundImplementation of evidence-based guidelines (EBGs) related to VAP is an effective measure for the prevention of ventilator-associated...
-
Microbial etiologies of ventilator-associated pneumonia (VAP) in intensive care unit of Beni-Suef University’s Hospital
BackgroundVentilator-associated pneumonia (VAP) is a major health problem for people intubated in intensive care units (ICUs), leading to increased...
-
Detection of bacteria via multiplex PCR in respiratory samples of critically ill COVID-19 patients with suspected HAP/VAP in the ICU
BackgroundCritically ill Coronavirus disease 2019 (COVID-19) patients have high rates of bacterial superinfection. Multiplex polymerase chain...
-
Recurrent ventilator-associated pneumonia in severe Covid-19 ARDS patients requiring ECMO support
ObjectiveTo describe ventilator-associated pneumonia (VAP) recurrence in COVID-19 patients requiring extracorporeal membrane oxygenation (ECMO)...
-
The spectrum of pneumonia among intubated neonates in the neonatal intensive care unit
We review the pathophysiology, epidemiology, diagnosis, treatment, and prevention of ventilator-associated pneumonia (VAP) in neonates. VAP has been...
-
Ventilator-associated pneumonia related to extended-spectrum beta-lactamase producing Enterobacterales during severe acute respiratory syndrome coronavirus 2 infection: risk factors and prognosis
BackgroundPatients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-COV 2) and requiring mechanical ventilation suffer from a...
-
Compliance to ventilator care bundles and its association with ventilator-associated pneumonia
PurposeVentilator care bundles are effective in the prevention of ventilator-associated pneumonia (VAP). However, the compliance of these bundles in...
-
Role of STREM-1 for early prediction of ventilator-associated pneumonia in pediatrics
BackgroundTREM-1 (setting off receptor imparted on myeloid cells-1) is an immunoreceptor. Neutrophils, monocytes/macrophages, and endothelial cells...
-
The clinical and neuroimaging differences between vascular parkinsonism and Parkinson’s disease: a case-control study
BackgroundParkinson’s disease (PD) and vascular parkinsonism (VaP) have highly overlap** phenotypes, and different prognosis. This study...
-
Antimicrobial Resistance in Ventilator-Associated Pneumonia: Predictive Microbiology and Evidence-Based Therapy
Ventilator-associated pneumonia (VAP) is a serious intensive care unit (ICU)-related infection in mechanically ventilated patients that is frequent,...
